Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Joseph M, Unger"'
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-9 (2023)
Abstract Background In April 2022, an outbreak of the SARS-CoV-2 virus Omicron variant in Shanghai precipitated an extensive lockdown. We assessed changes in healthcare utilization during this outbreak and investigated the relationship between the st
Externí odkaz:
https://doaj.org/article/8350d5466bb340cda446bc2fba5b06a8
Publikováno v:
Population Health Metrics, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background AMI and stroke are the leading causes of premature mortality and hospitalizations in China. Incidence data at the population level for the two diseases is limited and the reliability and completeness of the existing incidence regi
Externí odkaz:
https://doaj.org/article/a6dab436765449c185b6421c91e718bc
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The outbreak of the COVID-19 pandemic alarmed the public and initiated the uptake of preventive measures. However, the manner in which the public responded to these announcements, and whether individuals from different provinces responded si
Externí odkaz:
https://doaj.org/article/ac130d7996fe49a3a1b27311555655c3
Autor:
Shellie D. Ellis, Riha Vaidya, Joseph M. Unger, Kelly Stratton, Jessie Gills, Peter Van Veldhuizen, Eileen Mederos, Emily V. Dressler, Matthew F. Hudson, Charles Kamen, Heather B. Neuman, Anne E. Kazak, Ruth C. Carlos, Kathryn E. Weaver
Publikováno v:
Contemporary Clinical Trials Communications, Vol 29, Iss , Pp 100981- (2022)
Purpose: Urological cancer clinical trials face accrual challenges, which may stem from structural barriers within cancer programs. We sought to describe the extent to which urology cancer care providers are available within community cancer research
Externí odkaz:
https://doaj.org/article/8c2d27545e9a4539af11363ba6cbacad
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-10 (2021)
Abstract Background Patient-reported outcomes (PROs) can be used to monitor patients during treatment. Healthcare provider preferences for individualized vs. standardized PROs have been understudied. Methods This study surveyed oncology and mental he
Externí odkaz:
https://doaj.org/article/8303d659a3ad441d8730923b0ecbe82a
Autor:
Salene M.W. Jones, Joseph M. Unger
Publikováno v:
PAIN Reports, Vol 7, Iss 4, p e1015 (2022)
Introduction:. Current methods of determining minimally important differences (MIDs) in patient-reported outcomes (PROs) do not incorporate individual patient values. Objectives:. This study tested the feasibility of having cancer patients define a p
Externí odkaz:
https://doaj.org/article/e16c68e3f60a444ca3e1a1010b7f6e8b
Autor:
Joseph M. Unger, Hong Xiao
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-5 (2021)
Abstract Background The COVID-19 pandemic has caused severe disruptions in care for many patients. A key question is whether the landscape of clinical research has also changed. Methods In a retrospective cohort study, we examined the association of
Externí odkaz:
https://doaj.org/article/f64ed41c61934f6a8cd10446bc0a85fc
Autor:
Siu-Fun Wong, Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries, Anna Moseley, Kathryn Arnold, Mario R. Velasco, Justin D. Floyd, Benjamin T. Esparaz, Afsaneh Barzi, Heinz-Josef Lenz, Marianna Koczywas, Shaker Dakhil, Gary V. Burton, Michael J. Fisch, N. Lynn Henry, Dawn L. Hershman, Carol M. Moinpour
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-12 (2020)
Abstract Background Papulopustular rash is a common class effect of epidermal growth factor receptor inhibitors (EGFRI) that can affect patients’ health-related quality of life and cause disruptions to treatment. SWOG S1013 (NCT01416688) is a multi
Externí odkaz:
https://doaj.org/article/cc8f4d5ab8574139b368be4cd9f29553
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 7, Iss 3, Pp 239-248 (2020)
Purpose: Patient-reported outcomes (PROs) are frequently used in clinical care to monitor treatment response. However, most guidelines on PRO use treat all patients the same. This study tested the feasibility and validity of a method for determining
Externí odkaz:
https://doaj.org/article/d10a5f4b8355490c8877b0c74338cb97
Autor:
Michael E. Roth, Joseph M. Unger, Ann M. O'Mara, Mark A. Lewis, Troy Budd, Rebecca H. Johnson, Brad H. Pollock, Charles Blanke, David R. Freyer
Publikováno v:
Cancer Medicine, Vol 9, Iss 6, Pp 2146-2152 (2020)
Abstract Background Few adolescents and young adults (AYAs, 15‐39 years old) enroll onto cancer clinical trials, which hinders research otherwise having the potential to improve outcomes in this unique population. Prior studies have reported that A
Externí odkaz:
https://doaj.org/article/55acfd57bc5d44f6a4fefa5aa18677b3